In the adoptive cell therapy (ACT) setting, melanoma-specific TCR transgenic CD4+ T cells produced both IFN-γ and GzmB within tumors, suggesting that these cells have both helper and cytotoxic activities (Th-ctx). This evidence concerns the gene CD4 and melanoma.